Since mutant KRAS drives the activation of CAMP responsive element-binding (CREB), it is only appropriate to devise an inhibitor that can effectively do such through RAF/MEK/ERK signalling pathway inducing apoptosis in cancer cells [40]. This evidence concerns the gene CREB1 and cancer.